Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Level II Quotes ! Big Drop This AM
View:
Post by knoxt on Nov 28, 2024 10:22am

Level II Quotes ! Big Drop This AM

  •  
Comment by DeathXray33 on Nov 28, 2024 12:00pm
Do you see Anonymous buying shares by the wheel barrow? Like trying to buy a loaf of bread in East Germany.
Comment by StevenBirch on Nov 28, 2024 1:04pm
Of course they are because what has really changed? We don't get BTD in the next couple of weeks or by year end? Big deal. But anonymous probably started the selling this morning under their real name/number and probably got a few pessimists to sell. Probably not a lot gets done at this time of year and we were probably kidding ourselves to think it would. But I keep going back to the fact ...more  
Comment by Infinity on Nov 29, 2024 3:16am
What TLT lacks is clarity.  The clinical test results are all superior to existing FDA approved Treatments.  This MOM AND POP culture within the compamy  has to change for this company to be taken seriously
Comment by StevenBirch on Nov 29, 2024 7:58am
I say that this Black Friday nonsense has gone too far, now even TLT is at a massive discount? Hopefully cooler heads prevail and realize a little delay isn't the end of the world.
Comment by managementfirst on Nov 29, 2024 8:34am
I hope RTW will talk about the reasons for delay next week. From yesterdays news release, RTW and Mandel talked all about the figures, seems minor job needed for resubmiting.
Comment by N0taP00p on Nov 29, 2024 10:34am
Very little selling in the US despite the price drop,  unlike in Canada yesterday.  Normally, I would take that as a good sign. But with this stock who knows. US investors have probably put this in the Hail Mary category and mentally written this investment off.   
Comment by bmk211 on Nov 29, 2024 10:57am
Ya this is absolutely a hail mary.  Too many other drug companies have caught up.  This company fumbles around.   If it ever gets approved and continues to raise money and the technology develops ya I can see a huge payoff. So my money is going down with the ship.  But it just seems extremely unlikely they can survive against big pharma, FDA navigating, and other companies ...more  
Comment by blackjack0 on Nov 29, 2024 11:03am
Your true colours are showing! What new drugs are you referring to?? Please list 
Comment by blackjack0 on Nov 29, 2024 11:32am
Bmk you say Hail Mary : we are nearing the end of a phase 2 study with best in class data. You state other companies have caught up, like I said please list these companies, you said we are fumbling around. We have no say in the process and are at the mercy of the FDA and manipulators. (Like yourself)
Comment by bmk211 on Nov 29, 2024 11:33am
I am only speaking from ignorance of having no understanding how difficult it is to bring a drug to market.   All I am saying is that there is no way it is an easy road.   But one drug that showed good CR rate was from IBRX.   With cancer, time matters. Designated an FDA Breakthrough Therapy for BCG-unresponsive non-muscle invasive bladder ...more  
Comment by DeathXray33 on Nov 29, 2024 11:00am
This handsome U.S. investor bought today & is going to buy next Monday. --- Thanks & Good luck --- # Tender Loving Technology
Comment by bmk211 on Nov 29, 2024 11:42am
Yes probably will slowly keep adding more. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250